(Q34609589)

3 August 2017

1 reference

title

Manufacturing challenges in the commercial production of recombinant coagulation factor VIII. (English)

1 reference

3 August 2017

Jiang R

1

1 reference

3 August 2017

Monroe T

series ordinal

2

1 reference

3 August 2017

McRogers R

series ordinal

3

1 reference

3 August 2017

Larson PJ

series ordinal

4

1 reference

3 August 2017

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

8 Suppl 2

1 reference

3 August 2017

page(s)

1-5

1 reference

Characterization of the human factor VIII gene.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-8216.2001.00115.X

Molecular cloning of a cDNA encoding human antihaemophilic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-8216.2001.00115.X

Expression of active human factor VIII from recombinant DNA clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-8216.2001.00115.X

Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-8216.2001.00115.X

10.1046/J.1351-8216.2001.00115.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference